A Randomized Controlled Trial for 'Huoxue Tongluo Decoction' in Treating Erectile Dysfunction of Blood Stasis and Kidney Deficiency

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1 meet the diagnostic criteria of impotence (erectile dysfunction) Western medicine;
•2 meet the diagnostic criteria of impotence-blood stasis and kidney deficiency syndrome;
•3 male, aged 20 to 69 years, have the same conditions, normal sexual desire;
•4 IIEF-5<21 points;
•5 The course of disease is >= 12 weeks;
•6 people who have voluntarily signed informed consent.

•1 Allergic constitution and those who are allergic to experimental drugs;
•2 Patients with renal cancer, bladder tuberculosis, and urinary calculi;
•3 Combined with other malignant tumor patients;
•4 Patients with blood system diseases, coagulopathy and autoimmune diseases;
•5 Combined with severe cardiovascular disease, cerebrovascular disease, hematopoietic system disease, neuropathic patients;
•6 Participated in other clinical researchers 3 months before the trial.
•For the above 6 exclusion criteria, as long as one of the criteria is met, the exclusion criteria are met and need to be excluded.

发起方

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine